Clinical efficacy and safety of a beta3-adrenoceptor agonist (mirabegron) and an antimuscarinic agent (imidafenacin) in female patients with overactive bladder: a randomized crossover study

Torimoto K1, Matsushita C2, Yamada A3, Goto D3, Matsumoto Y4, Hosokawa Y2, Hirayama A5, Fujimoto K1

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 487
Pharmacotherapy for Overactive Bladder
Scientific Podium Short Oral Session 34
Friday 9th October 2015
09:00 - 09:07
515ABC
Clinical Trial Female Overactive Bladder Pharmacology Prospective Study
1. Nara Medical University, 2. Tane General Hospital, 3. Hirao Hospital, 4. Hoshigaoka Medical Center, 5. Nara Hospital Kinki University Faculty of Medicine
Presenter
K

Kazumasa Torimoto

Links

Abstract